Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aura Biosciences Inc
AURACurrent price
9.97 USD
-0.5 USD (-4.78%)
Last closed
10.33 USD
Company
www.aurabiosciences.com
ISIN
US05153U1079
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
539 714 368 USD
Yield for 12 month
+23.24 %
1Y
3Y
5Y
10Y
15Y
AURA
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmette"guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts. Address: 80 Guest Street, Boston, MA, United States, 02135
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
22.43 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+2 056 000 USD
Current Year
-1 295 000 USD
Last Year
-1 177 000 USD
Current Quarter
-313 000 USD
Last Quarter
-306 000 USD
Key Figures AURA
1 year
3 years
5 years
10 years
EBITDA
-89 062 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-27.48 %
PEG Ratio
–
Return On Equity TTM
-45.09 %
Wall Street Target Price
22.43 USD
Revenue TTM
–
Book Value
3.86 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.79 USD
Diluted Eps TTM
-1.79 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics AURA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AURA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation AURA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-5.6773
Price Book MRQ
2.819
Financials AURA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AURA
For 52 weeks
6.63 USD
12.38 USD
50 Day MA
9.57 USD
Shares Short Prior Month
1 150 851
200 Day MA
8.33 USD
Short Ratio
7.67
Shares Short
1 051 208
Short Percent
2.88 %
BeatStart